Cargando…

Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations

Type 2 diabetes mellitus is a chronic health problem that can be controlled by slowing one’s carbohydrate metabolism by inhibiting α-glucosidase, an enzyme responsible for carbohydrate degradation. Currently, drugs for type 2 diabetes have limitations in terms of safety, efficiency, and potency, whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashid, Rebwar Saeed M., Temurlu, Selin, Abourajab, Arwa, Karsili, Pelin, Dinleyici, Meltem, Al-Khateeb, Basma, Icil, Huriye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145898/ https://www.ncbi.nlm.nih.gov/pubmed/37111312 http://dx.doi.org/10.3390/ph16040555

Ejemplares similares

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
por: Abo-zeid, Yasmin, et al.
Publicado: (2020)

Synthesis of novel coumarin–hydrazone hybrids as α-glucosidase inhibitors and their molecular docking studies
por: Tariq, Hafiza Zara, et al.
Publicado: (2023)

Molecular Docking Study of Beta-Glucosidase with Cellobiose, Cellotetraose and Cellotetriose
por: Khairudin, Nurul Bahiyah Ahmad, et al.
Publicado: (2013)

Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition
por: Rahman, Noor, et al.
Publicado: (2019)

In vitro and molecular docking analysis of chalconeimine derivatives with α-glucosidase
por: Asaithambi, R, et al.
Publicado: (2020)

Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives
por: Ahmad, Ashfaq, et al.
Publicado: (2020)

Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2
por: Anwaar, Muhammad U., et al.
Publicado: (2022)

Inhibitory Effect of Fisetin on α-Glucosidase Activity: Kinetic and Molecular Docking Studies
por: Shen, Beiyun, et al.
Publicado: (2021)

Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
por: Arasu, M.Valan, et al.
Publicado: (2023)

Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs
por: Farhat, Nabeela, et al.
Publicado: (2021)

Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
por: Abuelizz, Hatem A., et al.
Publicado: (2019)

FDA recommended potent drugs against COVID-19: Insight through molecular docking
por: Gumber, Khushbu, et al.
Publicado: (2021)

Molecular docking analysis of FDA approved drugs with the glycoprotein from Junin and Machupo viruses
por: Malhotra, Himani, et al.
Publicado: (2022)

Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach
por: Alghamdi, Huda Ahmed, et al.
Publicado: (2021)

Screening of potential inhibitors of COVID-19 with repurposing approach via molecular docking
por: Alizadehmohajer, Negin, et al.
Publicado: (2022)

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors
por: Xie, Zhenzhen, et al.
Publicado: (2017)

Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives
por: Gong, Zipeng, et al.
Publicado: (2017)

Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Salvia aurita Constituents
por: Etsassala, Ninon G. E. R., et al.
Publicado: (2020)

Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking
por: Taha, Muhammad, et al.
Publicado: (2019)

Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
por: Etsassala, Ninon G. E. R., et al.
Publicado: (2022)

Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors
por: Pedrood, Keyvan, et al.
Publicado: (2022)

In-vitro high-throughput library screening—Kinetics and molecular docking studies of potent inhibitors of α-glucosidase
por: Ali, Majid, et al.
Publicado: (2023)

Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors
por: Aguila-Muñoz, Dolores G., et al.
Publicado: (2023)

Insight into the Inhibitory Mechanisms of Hesperidin on α-Glucosidase through Kinetics, Fluorescence Quenching, and Molecular Docking Studies
por: Kaliaperumal, Kumaravel, et al.
Publicado: (2023)

Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020)

Molecular docking-based screening of methicillin-resistant Staphylococcus aureus FEM proteins with FDA-approved drugs
por: Akkiraju, Anjini Gayatri, et al.
Publicado: (2023)

Treating Hyperglycemia From Eryngium caeruleum M. Bieb: In-vitro α-Glucosidase, Antioxidant, in-vivo Antidiabetic and Molecular Docking-Based Approaches
por: Sadiq, Abdul, et al.
Publicado: (2020)

Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies
por: yousif, Fatima A., et al.
Publicado: (2023)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
por: Huang, Yue, et al.
Publicado: (2022)

Synthesis of amantadine clubbed N-aryl amino thiazoles as potent urease, α-amylase & α-glucosidase inhibitors, kinetic and molecular docking studies
por: Zahra, Fatima Tuz, et al.
Publicado: (2023)

Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study
por: Ullah, Hayat, et al.
Publicado: (2022)

Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors
por: Gong, Zipeng, et al.
Publicado: (2017)

Alpha-Glucosidase Inhibitory Assay-Screened Isolation and Molecular Docking Model from Bauhinia pulla Active Compounds
por: Dej-adisai, Sukanya, et al.
Publicado: (2021)

Identification of novel α-glucosidase and ACE inhibitory peptides from Douchi using peptidomics approach and molecular docking
por: Guo, Weidan, et al.
Publicado: (2023)

Correction: In-vitro high-throughput library screening—Kinetics and molecular docking studies of potent inhibitors of α-glucosidase
Publicado: (2023)

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
por: Zulfiqar, Zikra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r1r4irv58g3j3f716gphhggc80